Mounjaro vs bmiMD

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Mounjaro vs bmiMD: Overview

Choosing between Mounjaro and bmiMD for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Mounjaro focuses on tirzepatide at $1080/month with a rating of 9.2/10. bmiMD also provides both semaglutide and tirzepatide at $129/month with a 8/10 rating.

The price difference of $951/month is significant - bmiMD is the more budget-friendly option, while Mounjaro positions itself as a premium service.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$951/mo
Rating Difference
1.2
Winner
Mounjaro
Best For
Quality

Mounjaro

View full Mounjaro review →
Rating
9.2/10Better
Monthly Price
$1080
Medications
tirzepatide

Pros

  • FDA-approved for type 2 diabetes
  • Weekly injection
  • Effective for weight loss (~15-20%)
  • Dual GIP/GLP-1 mechanism
  • Often covered by insurance for diabetes

Cons

  • Primarily approved for diabetes, not weight loss
  • Requires prescription
  • May cause nausea and digestive issues
  • Supply shortages reported
Choose Mounjaro

bmiMD

View full bmiMD review →
Rating
8/10
Monthly Price
$129Cheaper
Medications
semaglutidetirzepatidemetformin

Pros

  • The full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked July 26, 2026
  • You are not charged until a licensed provider confirms you are eligible. bmiMD authorises your card, releases the hold if you do not qualify, and states you 'won't incur any charges'
  • A 100% money-back guarantee if you are not approved for treatment, including the assessment
  • Unusually broad catalogue beyond GLP-1s: microdose semaglutide and tirzepatide, metformin from $19/mo, MIC + B12 from $69/mo, naltrexone/bupropion, sermorelin and NAD+
  • Free shipping on every subscription order and 24/7 clinician access included in the plan price
  • The compounded disclosure is explicit and specific, naming FDA-registered facilities while stating the drugs are not FDA-approved
  • Subscriptions can be cancelled or paused from your account rather than only by email

Cons

  • A $50 non-refundable cancellation fee applies if you cancel after your intake is approved but before the pharmacy processes the order - a charge most competitors do not levy
  • Once the prescription reaches the pharmacy, all sales are final: 'we do not offer refunds for partially used subscription periods'
  • The site runs constant price-increase pressure - a sitewide 'Prices increase soon, lock in today's rate before it goes up' banner, a 'Price increases in' countdown, 'LIMITED TIME' on every plan tier and 'Lock This Price Now' on every product
  • The homepage contradicts itself on tirzepatide, listing it at 'Starting as low as $149/mo' in one block and 'As low as $139/month' in another
  • The $99 headline requires committing to 12 months and paying $1,188 upfront; month to month is $129
  • This offer is not available in Alabama, Arkansas, California, Kentucky, Louisiana, Mississippi, North Carolina, North Dakota or South Carolina
  • No BBB profile and a relatively small Trustpilot sample mean limited independent history to check
  • No published customer phone number, and the compounded disclosure sits on product pages rather than the landing page
Choose bmiMD

Feature-by-feature comparison

FeatureMounjarobmiMD
Monthly Price$1080$129
Rating9.2/108/10
Medicationstirzepatidesemaglutide, tirzepatide, metformin
Insurance AcceptedYesNo
Support HoursMon-Fri 8AM-8PM ET24/7 clinician access claimed
Live ChatNoNo
Free ShippingNoYes
Shipping SpeedVaries by pharmacyFree shipping on subscription orders; timeframe not published
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyAs prescribed by physician24/7 clinician access with refills delivered on subscription
Money-back GuaranteeSavings card available ($25 per month for eligible patients)100% refund if you are not approved for treatment; otherwise all sales are final once the prescription reaches the pharmacy
Cancellation PolicyPrescription-based, consult doctorCancel or pause from your account any time, but a $50 non-refundable fee applies after intake approval and there are no refunds for partially used periods

Which should you choose?

Choose Mounjaro if you:

  • Prefer a higher-rated service (9.2/10 vs 8/10)
  • Need insurance coverage for your treatment
  • Value: fda-approved for type 2 diabetes

Choose bmiMD if you:

  • Want to save $951/month with a more affordable option
  • Want more medication options to choose from
  • Value: the full price ladder is published on the product page, not hidden behind a quiz: compounded semaglutide is $129 billed monthly, $119/mo on 3 months ($357), $109/mo on 6 months ($654) and $99/mo on 12 months ($1,188), checked july 26, 2026

Website previews

Mounjaro

Mounjaro website

bmiMD

bmiMD website

Our recommendation

Mounjaro comes out ahead with a higher rating of 9.2/10.
Get started with Mounjaro

Compare other providers

Compare GLP-1 Brands